Skip to main content
TipRanks
Go Ultimate75% OFF

Axon Enterprise (TCS) AI Stock Analysis

2 Followers
CH:TCS

Axon Enterprise

(BX Swiss:TCS)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recurring revenue growth and retentionRapid recurring-revenue growth and 126% net retention indicate customers are expanding their use of Axon’s software platform. This improves revenue visibility, supports cross-selling across workflows, and makes the hardware-plus-cloud model more durable over the next several quarters.
Negative Factors
Higher leverage and enlarged debt obligationsMaterially higher debt relative to equity reduces financial flexibility and increases the obligations that must be supported by future operating performance. Although the balance sheet remains adequately capitalized, elevated leverage can constrain acquisitions, investment and resilience if execution weakens.

Axon Enterprise (TCS) vs. iShares MSCI Switzerland ETF (EWL)

-40%-30%-20%-10%0%10%20%30%40%CH:TCS-34.13%EWL+16.05%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CHF 25.69B
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
98.3
Beta (1Y)
1.21
Revenue Growth
25.52%
EPS Growth
-13.57%
Country
Switzerland
Employees
5,100
Sector
Industrials
Sector Strength
63
Industry
Aerospace & Defense

Axon Enterprise Business Overview & Revenue Model

Company Description

Axon Enterprise, Inc., founded in 1993 and headquartered in Scottsdale, Arizona, was previously known as TASER International, Inc. until its rebranding in April 2017. The company specializes in the development, production, and sale of conducted energ...

Axon Enterprise Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|% Change Since:-24.53%|Next Earnings Date:Mar 02, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. Axon reported 28% third-quarter revenue growth, accelerating software and recurring-revenue performance, strong bookings, expanding AI and 911 adoption, large customer wins and a substantial Skydio investment. The principal challenges were delayed Federal Dedrone deployments, increased inventory spending that reduced free cash flow, memory-related margin pressure, a modest TASER revenue decline and the delayed Apollo Dart launch. Management nevertheless characterized underlying demand as strong and maintained confidence in long-term growth.

Positive Updates

Expanded Skydio Partnership and $1.2 Billion Investment
Axon announced an expanded commercial partnership with Skydio and an additional $1.2 billion investment, taking Axon's fully diluted ownership to 37%. Axon will be Skydio's exclusive public safety distributor in the U.S. and Canada, while the investment provides exposure to Skydio's autonomous-drone business.

Negative Updates

Federal Dedrone Deployment Delays
Three large Federal Dedrone deployments totaling approximately $130 million of revenue and $200 million of bookings were delayed. A $30 million deployment expected in Q3 and two deployments totaling approximately $100 million included in the Q4 forecast may not be completed this year. Management cited procurement, election-cycle timing, funding, site preparation, equipment installation, permitting, acceptance testing and other deployment requirements.

Company Guidance

Axon expects fourth quarter revenue of $990 million to $1.01 billion and fourth quarter adjusted EBITDA of approximately $245 million to $250 million, implying full year adjusted EBITDA of $924 million to $929 million or approximately 25.6% margin. The full year free cash flow expectation is $350 million to $400 million, compared to the prior target of $450 million; at the midpoint, conversion is about 40% and Q4 free cash flow alone would be approximately $450 million. The outlook no longer assumes 2 large Federal Dedrone deployments totaling approximately $100 million, which, combined with the $30 million deployment that moved out of Q3, represents approximately $130 million or nearly 500 basis points of growth this year; even without these materializing, the midpoint of growth for the year is still above 30% for the fifth straight year. Axon expects to reach target inventory levels in the first half of '27, with 2027 expected to include conservatively half a year of having an inventory investment, and expects to be back to 60% conversion by 2028. The current planning assumption is that elevated memory costs remain a headwind through '27 and '28, with pricing not continuing to increase materially from what is being seen today.

Axon Enterprise Risk Analysis

Axon Enterprise disclosed 51 risk factors in its most recent earnings report. Axon Enterprise reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Axon Enterprise Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

CH:TCS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DRSDRS78Outperform$9.38B25.8713.04%1.02%8.85%37.35%
LHXLHX75Outperform$50.71B25.2610.17%1.82%7.33%15.31%
SWBISWBI68Neutral$843.57M28.736.63%3.32%16.96%100.15%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
RGRRGR62Neutral$806.10M49.085.70%0.87%10.60%646.48%
AVAVAVAV55Neutral$5.97B-20.19-6.64%―84.44%-541.91%

* Industrials Sector Average

Performance Comparison

-50%0%50%100%CH:TCSAVAVLHXDRSSWBIRGRDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:TCS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CH:TCSAxon Enterprise, Inc.258.75-134.09-34.13%
AVAVAeroVironment, Inc.117.52-166.14-58.57%
LHXL3harris Technologies272.35-11.82-4.16%
DRSLeonardo Drs, Inc.35.181.283.77%
SWBISmith & Wesson Brands, Inc.15.677.7096.59%
RGRSturm, Ruger & Company, Inc.50.4520.5068.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.